WENA - anewmeds.com Qarzning balans kapitallashuviga nisbati
Anew Medical, Inc. (WENA) Parkinson va Altsgeymer kasalliklariga qarshi gen terapiyalarini ishlab chiqish orqali o'z portfelini diversifikatsiya qilmoqda. Biznesning muvaffaqiyati klinik sinovlar natijalari va tadqiqot va ishlanmalar (R&D) investitsiyalarining kirib kelishiga bog'liq. Shu bilan birga, kompaniya o'z neyrotexnologiyalariga ESG standartlari va bioetikani integratsiya qilmoqda. Balansdagi moliyaviy leverajning dinamik tendentsiyasi qarzni boshqarishni namoyish etadi, bunda ko'rsatkich 0.00 atrofida saqlanmoqda.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_WENA_-_Anew-Medical-Inc._-_Debt-to-Net-Assets-Ratio "Anew Medical, Inc. - WENA Qarzning balans kapitallashuviga nisbati (davr: 25.06.2024 - 17.09.2024) | 👁️GURU.Markets👁️")
anewmeds.com (WENA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Anew Medical, Inc.|WENA - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning kapitalga nisbati Anew Medical|WENA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Anew Medical, Inc.|WENA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli majburiyatlari Anew Medical
Kompaniyaning barcha koʻrsatkichlari tahlili:Anew Medical, Inc. (WENA)
Anew Medical, Inc. (WENA) barqarorligi murakkab farmatsevtika logistikasining xarajatlar samaradorligiga bog'liq. Balansdagi kapital qarz majburiyatlarini qanchalik qoplaydigini tahlil qilish orqali investor moliyaviy leverajning haqiqiy darajasini aniqlashi mumkin. Ushbu ko'rsatkich qarz olingan mablag'larning umumiy miqdorini kompaniyaning sof aktiv qiymati bilan solishtiradi. Ushbu indikatorning o'sishi kredit yuklamasi xavflarining ortganligidan dalolat beradi, bu esa biznesning adolatli qiymatini aniqlash uchun muhimdir.
Anew Medical, Inc. (WENA) raqobatchilari
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|VKTX (Viking Therapeutics) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar SUPN|Qarzning balans kapitallashuviga nisbati Catalyst Pharmaceuticals, Inc. CPRX|Qarzning balans qiymatiga nisbati Denali (DNLI)|HRMY: Balans kapitallashuviga qarzlar|BHVN - Balans qiymatiga qarzlar|AMLX: Qarzning balans qiymatiga nisbati|trevitherapeutics.com (TRVI) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Praxis Precision Medicines, Inc. PRAX|AVXL (Anavex) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati CBLL|Qarzning balans qiymatiga nisbati prothena.com|Alector, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar annexonbio.com (ANNX)|OMER - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Neurogene Inc NGNE|Balans kapitallashuviga qarzlar ACIU (AC Immune Corp)|VYGR - Sof aktivlarga qarzlar|NMRA (Neumora Therapeutics) - Balans kapitallashuviga qarzlar|scilexholding.com (SCLX) - Qarzning balans qiymatiga nisbati|TVGN (Tevogen Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ACOG|Qarzning balans kapitallashuviga nisbati Cognition Therapeutics (CGTX)|Qarzning balans kapitallashuviga nisbati Inhibikase Pharma IKT|Qarzning balans qiymatiga nisbati Cassava Sciences, Inc.|Qarzning sof aktivlarga nisbati Assertio Holdings ASRT|Balans kapitallashuviga qarzlar COYA (Coya)|VTGN: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati ovidrx.com|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CRVO|Qarzning balans qiymatiga nisbati Alterity Therapeutics Ltd (ATHE)|CLNN (Clene Inc.) - Qarzning balans qiymatiga nisbati|Sof aktivlarga qarzlar pepgen.com PEPG|Jupiter Neurosciences Inc - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Relmada Corp RLMD|ANVS (Annovis Bio, Inc.) - Balans kapitallashuviga qarzlar|GRCE: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Firefly Neuroscience|Klotho Neurosciences (KLTO) - Qarzning balans qiymatiga nisbati|NRSN (NeuroSense Therapeutics Ltd) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar RVPH|Qarzning balans kapitallashuviga nisbati MetaVia Inc MTVA|Qarzning balans qiymatiga nisbati neuraxis.com (NRXS)|HSDT: Balans kapitallashuviga qarzlar|PASG - Balans qiymatiga qarzlar|Neuphoria - Qarzning balans qiymatiga nisbati|NERV: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Athira Pharma, Inc. ATHA|ADXN (addextherapeutics.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ALZN (Alzamend Neuro Inc.)|Balans qiymatiga qarzlar Cyclerion|Balans kapitallashuviga qarzlar PTIX|Balans kapitallashuviga qarzlar KTTA (pasitheaclinics.com)|CRGT - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati avenuetx.com ATXI|BCLI (BrainStorm Cell Therapeutics) - Balans kapitallashuviga qarzlar|Cara Therapeutics Inc. (CARA) - Balans qiymatiga qarzlar|CHRO (Chromocell Therapeutics Corporation) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Eliem Therapeutics Inc.|ITCI - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati LBPH|Qarzning balans kapitallashuviga nisbati MRNS (Marinus Pharmaceuticals, Inc.)|Qarzning balans qiymatiga nisbati NKGen Biotech Inc (NKGN)|NRBO: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Sage Therapeutics Inc SAGE|Synaptogenix, Inc. (SNPX) - Balans kapitallashuviga qarzlar|TRVN - Qarzning balans qiymatiga nisbati|vigilneuro.com - Balans kapitallashuviga qarzlar|Cerevel Therapeutics Inc (CERE) - Sof aktivlarga qarzlar